About

Focus and scope

ARPHA Conference Abstracts (ACA) is an innovative open access publishing platform for conference abstracts in any field of science. Abstracts are authored, submitted, reviewed, edited and published within a single online collaborative environment.

Conference collections of abstracts can be divided in sub-collections, edited and managed by different conference conveners and editors. Each conference collection and each separate abstract is published under DOI in both, human- (semantic HTML, PDF) and machine-readable (XML) formats.  

The platform does not publish conventional research articles or full-text papers. The abstracts, however, can be enriched with data, citations, figures and tables on agreement with the publisher. Video recordings, posters and presentations can be uploaded in bulk and visualized on the abstract pages after the end of the conference.


Unique features

ACA demonstrates several innovations in both the technological and social aspects of the academic publishing practices. These are some of the features that make the journal unique in its field:

  • The journal is published on ARPHA, the first online collaborative platform and workflow ever to support the full lifecycle of a manuscript, from writing through submission, peer-review, publication and dissemination.

  • Most structural elements of the published article – text, tables, figures, etc. are treated and stored as data.

  • The online, collaborative, manuscript-authoring ARPHA Writing Tool provides a large set of pre-defined, but flexible, article templates covering most important types of research outcomes. Within ARPHA, authors may work collaboratively on a manuscript and invite external contributors, such as mentors, potential reviewers, linguistic and copy editors, colleagues, who may correct and comment on the text before submission.

  • A rich set of functionalities of the ARPHA Writing Tool allows for search and import of literature and data references, cross-referencing of in-text citations of literature, tables, images and supplementary material. The tool has an automated technical validation step which will save your time by checking your manuscript for consistency.

  • Аll reviews on a manuscript are consolidated into a single online file which makes the process of editing straightforward, easy and comfortable. The journal allows also a post-publication review.

  • After the end of the conference, the presentations, Video recordings and posters can be uploaded and visualized at the respective abstract pages.


How It Works

Authoring and submission of abstracts

To write and submit a conference abstract to ACA, the authors need to:

  1. Log in at the journal’s website.
  2. Create a new Conference abstract manuscript via the ARPHA Writing Tool by clicking the "Start a Conference Abstract" button on the journal’s homepage.
  3. Fill in the mandatory metadata along with the text of the abstract.
  4. Assign their manuscript to an existing collection by clicking on the Collections-button located in the top menu. (Note:  If the authors have assigned the abstract to a wrong collection, the editors can change it during the technical evaluation process, prior to the submission to ACA.)
  5. Pass the validation (i.e. automated check for empty mandatory fields).
  6. Have their conference abstract accepted for a particular collection from the respective editor (this may take several iterations depending on the collection editor’s comments and subsequent decision) (note: not all collections require approval of the abstracts assignment. For most of them it is done automatically).
  7. Submit their conference abstract for publication to the journal.

Extended guidelines with screenshots are available in this blog. The reader may also consult a shortened guidelines version below.

Manuscripts intended for submission to ACA, should be written in the collaborative online ARPHA Writing Tool. ARPHA provides flexible abstract templates upon clicking on the "Start a Conference Abstract" button. ARPHA further provides a rich set of functionalities, which makes the collaborative work easy and comfortable for both the authors and their peers. The authoring process in ARPHA is described in fine detail in the Tips and Tricks menu of the writing tool.

Abstracts in ACA are being grouped in separate collections and/or sub-collections, which on the other hand are edited and managed by different conference conveners and editors. Assigning an abstract to a collection from a preset list of collections open at the time of submission is mandatory. To assign a manuscript to a certain collection of proceedings, authors can request it be added to that collection still during the authoring process in the ARPHA Writing Tool. The abstract will be accepted to a collection as soon as one of the editors handling the relevant collection approves it (whereas a convener/editor’s approval is needed).

ARPHA Writing Tool provides an automated technical pre-submission validation to save your time by checking your manuscript for consistency. By clicking at the Validation button, an automated technical check will run through the submission and alert the author if there are any mandatory elements missing. If any technical problems are detected by the system, a pop-up window will indicate each issue encountered. Clicking on the links for each error will guide the author to the relevant place, where the issue should be addressed.

In addition, a pre-submission technical and editorial review is performed by the editors against formal checklist criteria such as: technical consistency, language, ethical issues, correspondence to the journal’s criteria for publication, focus and scope. The editors of ACA can re-iterate the technical evaluation process several times until the manuscript reaches an acceptable level of quality to be submitted to ACA.


Policies

General Statement

The journal policies and guidelines are mandatory. Exceptions to elements of the policies may be granted in specific cases, but will require justification that will be made public together with the article.

License and Copyright Agreement

In submitting the manuscript to the journal, the authors certify that:

  • They are authorized by their co-authors to enter into these arrangements.
  • The work described has not been formally published before (except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal), that it is not under consideration for publication elsewhere, that its publication has been approved by all the author(s) and by the responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
  • They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
  • They agree to the following license and copyright agreement:

Copyright

Licensing for Data Publication

Pensoft’s  journals use a variety of waivers and licenses, that are specifically designed for and appropriate for the treatment of data:

Other data publishing licenses may be allowed as exceptions (subject to approval by the editor on a case-by-case basis) and should be justified with a written statement from the author, which will be published with the article.

Open Data and Software Publishing and Sharing

The journal strives to maximize the replicability of the research published in it. Authors are thus required to share all data, code or protocols underlying the research reported in their articles. Exceptions are permitted, but have to be justified in a written public statement accompanying the article.

Datasets and software should be deposited and permanently archived in appropriate, trusted, general, or domain-specific repositories (please consult http://service.re3data.org and/or software repositories such as GitHubGitLabBioinformatics.org, or equivalent). The associated persistent identifiers (e.g. DOI, or others) of the dataset(s) must be included in the data or software resources section of the article. Reference(s) to datasets and software should also be included in the reference list of the article with DOIs (where available). Where no domain-specific data repository exists, authors should deposit their datasets in a general repository such as ZENODODryadDataverse, or others.

Small data may also be published as data files or packages supplementary to a research article, however, the authors should prefer in all cases a deposition in data repositories.

Privacy Statement

The names and email addresses present on the journal’s website will be used exclusively for the purposes of the journal.

Author Policies

It is a responsibility of the corresponding author that all named authors have agreed to its submission.

The Corresponding Author’s Role and Responsibilities are to:

  1. Inform all co-authors of the submission of the manuscript to the journal (note: each co-author will receive a confirmation email upon submission and will need to confirm their authorship).
  2. Manage all correspondence between the journal and all co-authors, keeping the full co-author group apprised of the manuscript progress.
  3. Designate a substitute correspondent for times of unavailability.
  4. Ensure payment of the publication charges at the point of Editorial Acceptance, or before that in case some specific services have been purchased (e.g., conversion to ARPHA or linguistic editing).
  5. Ensure that the manuscript is in full adherence with all the journal policies (including such items as publication ethics, data deposition, materials deposition, etc).
  6. Post Publication: Respond to all queries pertaining to the published manuscript, provide data and materials as requested.
  7. The submission must be created (and completed) by one of the co-authors, not by an agency, or by some other individual who is not one of the co-authors.

Commenting Policies

All public comments follow the normal standards of professional discourse. All commenters are named, and their comments are associated to the journal profile. The journal does not allow anonymous or pseudonymous commenting or user profiles.

The journal does not tolerate language that is insulting, inflammatory, obscene or libelous. The journal reserves the right to remove all or parts of Comments to bring them in line with these policies. The journal is the final arbiter as to the suitability of any comments.

Conflicts of Interest

The journal requires that all parties involved in a publication (i.e. the authors, reviewers and academic editors) should transparently declare any potential Conflicts of Interest (also known as Competing Interests). The disclosure of a Conflict of Interest does not necessarily mean that there is an issue to be addressed; it simply ensures that all parties are appropriately informed of any relevant considerations while they work on the submission.

Potential Conflicts of Interest should be declared even if the individual in question feels that these interests do not represent an actual conflict. Examples of Conflicts of Interest include, but are not limited to: possible financial benefits if the manuscript is published; patent activity on the results; consultancy activity around the results; personal material or financial gain (such as free travel, gifts, etc.) relating to the work, and so on.

While possible financial benefits should appear here, actual funding sources (institutional, corporate, grants, etc.) should be detailed in the funding disclosure statement.

Funding Disclosure

The journal requires that authors declare the funding which made their work possible, including funding programmes, projects, or calls for grant proposals (when applicable).


Terms of Use

This document describes the Terms of Use of the services provided by the ARPHA Conference Abstracts platform, hereinafter referred to as "the Platform" or "this Platform". All Users agree to these Terms of Use when signing up to this Platform. Signed Platform Users will be hereinafter referred to as "User" or "Users".

The publication services to the Platform are provided by Pensoft Publishers Ltd., through its publishing platform ARPHA, hereinafter referred to as "the Provider".

The Provider reserves the right to update the Terms of Use occasionally. Users will be notified via posting on the site and/or by email. If using the services of the Platform after such notice, the User will be deemed to have accepted the proposed modifications. If the User disagrees with the modifications, he/she should stop using the Platform services. Users are advised to periodically check the Terms of Use for updates or revisions. Violation of any of the terms will result in the termination of the User's account. The Provider is not responsible for any content posted by the User in the Platform.

Account Terms

  1. For registration in this Platform or any of the services or tools hosted on it, Users must provide their full legal name, a valid email address, postal address, affiliation (if any),  and any other information requested.
  2. Accounts created via this Platform automatically sign in the User to the ARPHA Platform.
  3. Users are responsible for maintaining the security of their account and password. The Platform cannot and will not be liable for any loss or damage from failure to comply with this security obligation.
  4. Users are solely responsible for the content posted via the Platform services (including, but not limited to data, text, files, information, usernames, images, graphics, photos, profiles, audio and video clips, sounds, applications, links and other content) and all activities that occur under their account.
  5. Users may not use the service for any illegal or unauthorised purpose. Users must not, in the use of the service, violate any laws within their jurisdiction (including but not limited to copyright or trademark laws).
  6. Users can change or pseudonomyse their personal data, or deactivate their accounts at any time through the functionality available in the User’s personal profile. Deactivation or pseudonomysation will not affect the appearance of personal data in association with an already published work of which the User is author, co-author, editor, or reviewer.
  7. Users can report to the Platform uses of their personal data, that they might consider not corresponding to the current Terms of Use.
  8. The User’s personal data is processed by the Platform on the legal basis corresponding to Article 6, paragraph 1, letters a, b, c and f. of the General Data Protection Regulation (hereinafter referred to as GDPR) and will be used for the purpose of Platform’s services in accordance with the present Terms and Use, as well as in those cases expressly stated by the legislation.
  9. User’s consent to use the information the Platform has collected about the User corresponds to Article 6(1)(a) of the GDPR.
  10. The ‘legitimate interest’ of the Platform to engage with the User and enable him/her to participate in Platform’s activities and use Platform's services correspond to Article 6(1)(f) of the GDPR.

Services and Prices

The Provider reserves the right to modify or discontinue, temporarily or permanently, the services provided by the Platform. Plans and prices are subject to change upon 30 days notice from the Provider. Such notice may be provided at any time by posting the changes to the relevant service website.

Ownership

The Authors retain full ownership to their content published in the Platform. We claim no intellectual property rights over the material provided by any User in this Platform. However, by setting pages to be viewed publicly (Open Access), the User agrees to allow others to view and download the relevant content. In addition, Open Access articles might be used by the Provider, or any other third party, for data mining purposes.

The Provider reserves the rights in its sole discretion to refuse or remove any content that is available via the Website.

Copyrighted Materials

Unless stated otherwise, the Platform website may contain some copyrighted material (for example, logos and other proprietary information, including, without limitation, text, software, photos, video, graphics, music and sound - "Copyrighted Material"). The User may not copy, modify, alter, publish, transmit, distribute, display, participate in the transfer or sale, create derivative works or, in any way, exploit any of the Copyrighted Material, in whole or in part, without written permission from the copyright owner. Users will be solely liable for any damage resulting from any infringement of copyrights, proprietary rights or any other harm resulting from such a submission.

Exceptions from this rule are e-chapters or e-articles published under Open Access (see below), which are normally published under Creative Commons Attribution 3.0 license (CC-BY), or Creative Commons Attribution 4.0 license (CC-BY), or Creative Commons Public Domain license (CC0).

Open Access Materials

This Platform is a supporter of open science. Open access to content is clearly marked, with text and/or the open access logo, on all materials published under this model. Unless otherwise stated, open access content is published in accordance with the Creative Commons Attribution 4.0 licence (CC-BY). This particular licence allows the copying, displaying and distribution of the content at no charge, provided that the author and source are credited.

Privacy Statement

  1. Users agree to submit their personal data to this Platform, hosted on the ARPHA Platform provided by Pensoft.
  2. The Platform collects personal information from Users (e.g., name, postal and email addresses, affiliation) only for the purpose of its services.
  3. All personal data will be used exclusively for the stated purposes of the website and will not be made available for any other purpose or to third parties.
  4. In the case of co-authorship of a work published through the Platform services, each of the co-authors states that they agree that their personal data be collected, stored and used by the Platform.
  5. In the case of co-authorship, each of the co-authors agrees that their personal data publicly available in the form of a co-authorship of a published work, can be distributed to external indexing services and aggregators for the purpose of the widest possible distribution of the work they co-author.
  6. When one of the co-authors is not registered in the Platform, it is presumed that the corresponding author who is registered has requested and obtained his/her consent that his/her personal data will be collected, stored and used by the Platform.
  7. The registered co-author undertakes to provide an e-mail address of the unregistered author, to whom the Platform will send a message in order to give the unregistered co-author’s explicit consent for the processing of his/her personal data by the Platform.
  8. The Platform is not responsible if the provided e-mail of the unregistered co-author is inaccurate or invalid. In such cases, it is assumed that the processing of the personal data of the unregistered co-author is done on a legal basis and with a given consent.
  9. The Platform undertakes to collect, store and use the provided personal data of third parties (including but not limited to unregistered co-authors) solely for the purposes of the website, as well as in those cases expressly stated by the legislation.
  10. Users can receive emails from Platform and its hosting platform ARPHA, provided by Pensoft, about activities they have given their consent for. Examples of such activities are:
    • Email notifications to authors, reviewers and editors who are engaged with authoring, reviewing or editing a manuscript submitted to the Platform.
    • Email alerts sent via email subscription service, which can happen only if the User has willingly subscribed for such a service. Unsubscription from the service can happen through a one-click link provided in each email alert notification.
    • Information emails on important changes in the system or in its Terms of Use which are sent via Mailchimp are provided with "Unsubscribe" function.
  11. Registered users can be invited to provide a peer review on manuscripts submitted to the Platform. In such cases, the users can decline the review invitation through a link available on the Platform’s website.
  12. Each provided peer review can be registered with external services (such as Publons). The reviewer will be notified if such registration is going to occur and can decline the registration process.
  13. In case the Platform starts using personal data for purposes other than those specified in the Terms of Use, the Platform undertakes to immediately inform the person and request his/her consent.
  14. If the person does not give his/her consent to the processing of his or her personal data pursuant to the preceding paragraph, the Platform shall cease the processing of the personal data for the purposes for which there is no consent, unless there is another legal basis for the processing.
  15. Users can change/correct their personal data anytime via the functionality available in the User’s profile. Users can request the Platform to correct their personal data if the data is inaccurate or outdated and the Platform is obliged to correct the inaccurate or outdated personal data in a timely manner.
  16. Users may request the Platform to restrict the use of their personal data insofar as this limitation is not contrary to the law or the Terms of Use.
  17. Users may request their personal data to be deleted (the right to be forgotten) by the Platform, provided that the deletion does not conflict with the law or the Terms of Use.
  18. The User has the right to be informed:
    • whether his or her personal data have been processed;
    • for which purposes the Platform processes the personal data;
    • the ways in which his/her personal data are processed;
    • the types of personal data that Platform processes.
  19. The user undertakes not to interfere with and impede the Platform’s activities in the exercise of the provided rights.
  20. In case of non-fulfilment under the previous paragraph, the Platform reserves the right to delete the user's profile.

Disclaimer of Warranty and Limitation of Liability

Neither Pensoft and its affiliates nor any of their respective employees, agents, third party content providers or licensors warrant that the Platform service will be uninterrupted or error-free; nor do they give any warranty as to the results that may be obtained from use of the Platform, or as to the accuracy or reliability of any information, service or merchandise provided through Platform.

Legal, medical, and health-related information located, identified or obtained through the use of the Service, is provided for informational purposes only and is not a substitute for qualified advice from a professional.

In no event will the Provider, or any person or entity involved in creating, producing or distributing Platform or the contents included therein, be liable in contract, in tort (including for its own negligence) or under any other legal theory (including strict liability) for any damages, including, but without limitation to, direct, indirect, incidental, special, punitive, consequential or similar damages, including, but without limitation to, lost profits or revenues, loss of use or similar economic loss, arising from the use of or inability to use the Platform. The User hereby acknowledges that the provisions of this section will apply to all use of the content on Platform. Applicable law may not allow the limitation or exclusion of liability or incidental or consequential damages, so the above limitation or exclusion may not apply to the User. In no event will Pensoft’s total liability to the User for all damages, losses or causes of action, whether in contract, tort (including own negligence) or under any other legal theory (including strict liability), exceed the amount paid by the User, if any, for accessing Platform.

Third Party Content

The Provider is solely a distributor (and not a publisher) of SOME of the content supplied by third parties and Users of the Platform. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by third parties, including information providers and Users, are those of the respective author(s) or distributor(s) and not of the Provider.


Publication Ethics and Malpractice Statement

General

Manuscripts submitted to the Platform must be original work and is not currently being considered for publication by another journal.

The publishing ethics and malpractice policies of the Platform follow the relevant COPE guidelines (http://publicationethics.org/resources/guidelines), and in case a malpractice is suspected, the Platform Editors will act in accordance with them.

Misconduct

Research misconduct may include: (a) manipulating research materials, equipment, or processes, (b) changing or omitting data or results such that the research is not accurately represented in the article.

A special case of misconduct is plagiarism, which is the appropriation of another person's ideas, processes, results, or words without giving appropriate credit.

Research misconduct does not include honest error or differences of opinion.

If misconduct is suspected, Platform Editors will act in accordance with the relevant COPE guidelines: http://publicationethics.org/resources/guidelines.

Should a comment on potential misconduct be submitted by the Reviewers or Editors, an explanation will be sought from the Authors. If this is satisfactory, and a mistake or misunderstanding has taken place, the matter can be resolved. If not, the manuscript will be rejected, and the Editors will impose a ban on that individual's publication in the Platform for a period of three years.

In cases of published plagiarism or dual publication, an announcement will be made in the Platform, explaining the situation.

Appeals and Open Debate

We encourage academic debate and constructive criticism. Authors do not have a right to neglect unfavourable comments about their work and to choose not to respond to criticisms.

No Reviewer’s comment or published correspondence may contain a personal attack on any of the Authors. Criticism of the work is encouraged, and Editors should edit (or reject) personal or offensive statements.

The Author(s) should submit their appeal on editorial decisions to the Editorial Office.

The Platform encourages publication of open opinions, forum papers, corrigenda, critical comments on a published paper and Author’s response to criticism.

Retractions

The Platform reserves the right to retract articles that are found to be fraudulent or in breach of the Platform’s policies.


Writing a Press Release

Pensoft’s experienced PR team puts a lot of effort in the wide dissemination of the works we publish through press releases, news aggregators, blogs, social network communication and the mass media.

It goes without saying that press releases and news stories can have a major effect on the impact and popularity of research findings. Moreover, they are of benefit to all parties involved: the authors, their institutions, funding agencies, publishers and the society in general. Thanks to a well-established dissemination network, Pensoft press releases regularly provide the basis for print, online, radio and TV news stories in reputed international media outlets, including National GeographicBBCSky NewsCNNNew York TimesThe GuardianDeutsche WelleDer StandardDR, etc.

Here are some examples of Pensoft's press releases, posted on EurekAlert, which have enjoyed high popularity and thousands of views within the first days following their publication:

Our PR team invites you to prepare (or request) a short press release on your accepted paper whenever you find your research of public interest. We have provided a template and instructions to guide you through the specific text format.

We are always happy to promote your research by preparing a press release for you and coordinating our dedicated PR campaigns with the PR offices of our partnering institutions. You are welcome to approach us with your press release drafts or any queries regarding our PR campaign via email at either pressoffice@pensoft.net, or dissemination@pensoft.net.

To keep up with the latest news, subscribe to our blog and follow us on TwitterFacebook and Google+. Also, keep an eye on EurekAlert! for our top breaking stories!